Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
114.00    2.50 (2.24%)
Bid:
112.00
Ask:
116.00
Spread: 4.00 (3.571%)
Market Cap: £68.59m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Partnership with OneSpan

20 May 2026 07:00

RNS Number : 7989E
Intercede Group PLC
20 May 2026
 

20 May 2026

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

Intercede partners with OneSpan to accelerate enterprise adoption of FIDO passkeys

Strategic reseller partnership to expand Intercede's reach into the high-growth enterprise passkey market

Intercede (AIM: IGP), the leading cybersecurity software company specialising in digital identities, is pleased to announce that it has signed a new reseller agreement with OneSpan. OneSpan is a leading global authentication provider, trusted by more than 60% of the world's 100 largest banks, with deep expertise in regulated industries. Through this partnership, Intercede's MyID platform will provide full credential lifecycle management and simplified provisioning, enabling enterprises to deploy and manage FIDO2 passkeys at scale without the operational burden typically associated with high-volume hardware security key rollouts.

 

Under the terms of the agreement, OneSpan will resell Intercede's MyID Solutions suite, with a particular focus on MyID CMS, together with its Digipass-as-a-Service offering through its global channel and go-to-market ecosystem to target new enterprise customers. The partnership has been structured to capitalise on the accelerating enterprise demand for FIDO-based authentication and phishing-resistant passkeys. This forms part of Intercede's stated strategy of broadening routes to market through high-quality channel partners.

Intercede's MyID CMS, integrated with OneSpan's Digipass-as-a-Service offering, is uniquely positioned to address the enterprise passkey opportunity. As the first credential management system to support FIDO Enterprise Attestation, MyID CMS provides organisations with device-level identification and control supporting Entra ID environments. Through this partnership, Intercede combines OneSpan's production, distribution, and provisioning services for Digipass FIDO2 security keys with lifecycle management capabilities of MyID CMS, delivering a complete enterprise-grade passkey management solution.

Klaas van der Leest, Chief Executive of Intercede, commented:

"FIDO passkeys represent a significant shift in enterprise authentication and this agreement with OneSpan is a key step in scaling our go-to-market strategy. Their global reach, technical sales capability and strong-customer relationships are highly complementary to our product portfolio, expand our addressable market and continue to build out our channel ecosystem".

Shaun Bierweiler, Chief Revenue Officer at OneSpan commented:

" By integrating Intercede's MyID with OneSpan's Digipass-as-a-Service platform, we are delivering a best-of-breed authentication solution designed for enterprise-scale deployments and the high-assurance requirements of regulated organisations. Together, we are helping customers accelerate the adoption of strong, phishing-resistant authentication with confidence."

 

 

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Klaas van der Leest

Chief Executive Officer

Nitil Patel

Chief Financial Officer

Cavendish Capital Markets Limited

Tel. +44 (0)20 7220 0500

Marc Milmo / Fergus Sullivan/Trisyia Jamaludin

Corporate Finance

Matt Lewis/Brittany Stevens

ECM

 

About Intercede

Intercede is a cybersecurity software company specialising in digital identities and strong authentication, and its innovative solutions enable organisations to protect themselves against the number one cause of data breach: compromised user credentials.

 

The Intercede suite of products allows customers to choose the level of security that best fits their needs, from Secure Registration and ID Verification to Password Security Management, One-Time Passwords, FIDO and PKI. Uniquely, Intercede provides the entire set of authentication options from Passwords to PKI, supporting customers on their journey to passwordless and stronger authentication environments. In addition to developing and supporting Intercede software, the Group offers professional services and development capabilities as well as managing the world's largest password breach database.

 

For over 20 years, global customers in government, aerospace and defence, financial services, healthcare, telecommunications, cloud services and information technology have trusted Intercede solutions and expertise in protecting their mission critical data and systems at the highest level of assurance.

 

For more information visit: www.intercede.com

 

About OneSpan

 

OneSpan helps organisations build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity and Digital Agreements. Our cybersecurity solutions protect identities, secure mobile apps, and safeguard access through advanced high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks.Our digital agreement solutions streamline agreement workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and exceptional customer experiences. Trusted by leading global enterprises, including more than 60% of the world's 100 largest banks, OneSpan processes over 100 million digital agreements and billions of secure authentication transactions across more than 120 countries each year.

 

For more information, visit our website, explore our blog, or follow us on LinkedIn or YouTube.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFIDEAITLIR
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report
26th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.